ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

PHILLIP HOFFSTEN M. D.

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,676Medicare Part D Prescriptions Filled, Including Refills

Rank: 16 out of 103

$908K Total Retail Price of All Prescriptions

Rank: 4 out of 103

435 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
49% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Dakota
Lower avg

Schedule Two
Controlled Substances

17% of this provider’s 435 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

15% of this provider’s 435 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 12,059 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Dakota
OMEPRAZOLE 495 448 1 3
FUROSEMIDE 472 456 2 4
LEVOTHYROXINE SODIUM 456 438 3 1
SIMVASTATIN 434 404 4 2
WARFARIN SODIUM 381 315 5 7
FENTANYL 332 242 S2 6 34
HYDROCODONE-ACETAMINOPHEN 328 297 S3 7 11
LACTULOSE 275 252 8 139
PREDNISONE 268 264 9 24
CARVEDILOL 263 246 10 20
CITALOPRAM HBR 255 244 11 15
HYDROCHLOROTHIAZIDE 221 199 12 16
AMLODIPINE BESYLATE 197 189 13 6
LISINOPRIL 196 188 14 5
POTASSIUM CHLORIDE 196 171 14 10
ZOLPIDEM TARTRATE 195 180 16 29
MELOXICAM 176 134 17 49
DIOVAN 170 170 18 40
METFORMIN HCL 169 154 19 13
ALLOPURINOL 157 153 20 26
DIGOXIN 148 148 21 25
KLOR-CON 10 138 138 22 45
CARBIDOPA-LEVODOPA 136 124 23 55
OXYCODONE-ACETAMINOPHEN 136 92 S2 23 123
ROPINIROLE HCL 129 111 25 77
JANUVIA 127 126 26 71
NEXIUM 125 125 27 43
METOPROLOL TARTRATE 121 117 28 9
LOSARTAN POTASSIUM 114 108 29 12
GABAPENTIN 111 109 30 22
ATORVASTATIN CALCIUM 106 106 31 18
ALENDRONATE SODIUM 104 98 32 19
TAMSULOSIN HCL 101 100 33 23
IRBESARTAN 99 99 34 125
NAMENDA 99 99 34 41
DIOVAN HCT 99 99 34 129
MIRTAZAPINE 98 86 37 36
CLOPIDOGREL 96 92 38 32
METOPROLOL SUCCINATE 90 86 39 8
CLONIDINE HCL 86 86 40 82
FLUTICASONE PROPIONATE 86 74 40 35
BACLOFEN 85 39 42 150
SERTRALINE HCL 84 57 43 21
DONEPEZIL HCL 84 84 43 28
PLAVIX 82 73 45 46
CRESTOR 80 67 46 27
LOSARTAN-HYDROCHLOROTHIAZIDE 76 73 47 47
BUMETANIDE 76 75 47 132
ZETIA 74 61 49 66
LEVOFLOXACIN 72 60 50 57
CIPROFLOXACIN HCL 68 58 51 59
AMLODIPINE BESYLATE-BENAZEPRIL 67 54 52 118
LANTUS 64 58 53 39
RISPERIDONE 63 63 54 88
DETROL LA 63 63 54 146
BUDESONIDE 63 51 54 163
SULFAMETHOXAZOLE-TRIMETHOPRIM 62 51 57 107
OLANZAPINE 60 42 58 136
LOVASTATIN 60 44 58 67
KLOR-CON M20 59 59 60 56
TRAMADOL HCL 57 39 61 17
LISINOPRIL-HYDROCHLOROTHIAZIDE 57 54 61 48
OXYCONTIN 56 56 S2 63 140
ATENOLOL 55 42 64 14
EXFORGE 53 53 65 228
FLUCONAZOLE 52 14 66 151
INSULIN SYRINGE 52 30 66 75
RENVELA 51 31 68 237
LATANOPROST 50 43 69 240
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 18, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.